Literature DB >> 25621562

Asbestosis and environmental causes of usual interstitial pneumonia.

Mridu Gulati1, Carrie A Redlich.   

Abstract

PURPOSE OF REVIEW: Recent epidemiologic investigations suggest that occupational and environmental exposures contribute to the overall burden of idiopathic pulmonary fibrosis (IPF). This article explores the epidemiologic and clinical challenges to establishing exposure associations, the current literature regarding exposure disease relationships and the diagnostic work-up of IPF and asbestosis patients. RECENT
FINDINGS: IPF patients demonstrate a histopathologic pattern of usual interstitial pneumonia. In the absence of a known cause or association, a usual interstitial pneumonia pattern leads to an IPF diagnosis, which is a progressive and often terminal fibrotic lung disease. It has long been recognized that asbestos exposure can cause pathologic and radiographic changes indistinguishable from IPF. Several epidemiologic studies, primarily case control in design, have found that a number of other exposures that can increase risk of developing IPF include cigarette smoke, wood dust, metal dust, sand/silica and agricultural exposures. Lung mineralogic analyses have provided additional support to causal associations. Genetic variation may explain differences in disease susceptibility among the population.
SUMMARY: An accumulating body of literature suggests that occupational and environmental exposure can contribute to the development of IPF. The impact of exposure on the pathogenesis and clinical course of disease requires further study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25621562      PMCID: PMC4472384          DOI: 10.1097/MCP.0000000000000144

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  55 in total

Review 1.  Lung transplant in idiopathic pulmonary fibrosis.

Authors:  Timothy J George; George J Arnaoutakis; Ashish S Shah
Journal:  Arch Surg       Date:  2011-10

2.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

3.  Validation of the international labour office digitized standard images for recognition and classification of radiographs of pneumoconiosis.

Authors:  Cara N Halldin; Edward L Petsonk; A Scott Laney
Journal:  Acad Radiol       Date:  2014-03       Impact factor: 3.173

4.  Pulmonary fibrosis associated with aluminum trihydrate (Corian) dust.

Authors:  Ganesh Raghu; Bridget F Collins; Daniel Xia; Rodney Schmidt; Jerrold L Abraham
Journal:  N Engl J Med       Date:  2014-05-29       Impact factor: 91.245

5.  Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis.

Authors:  R Hubbard; S Lewis; K Richards; I Johnston; J Britton
Journal:  Lancet       Date:  1996-02-03       Impact factor: 79.321

6.  Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey.

Authors:  Sang Hoon Lee; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Soo Taek Uh; Choon Sik Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jeong Sup Song; Jong Wook Shin; Nam Soo Yoo; Eun Joo Lee; Jin Hwa Lee; Yangin Jegal; Hyun Kyung Lee; Moo Suk Park
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

7.  Low-dose computed tomography (LDCT) in workers previously exposed to asbestos: detection of parenchymal lung disease.

Authors:  Maria Claudia Carrillo; Samira Alturkistany; Heidi Roberts; Elsie Nguyen; Tae Bong Chung; Narinder Paul; Stephen Herman; Gordon Weisbrod; Demetris Patsios
Journal:  J Comput Assist Tomogr       Date:  2013 Jul-Aug       Impact factor: 1.826

8.  Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis--elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases.

Authors:  Hideya Kitamura; Shizuko Ichinose; Takumi Hosoya; Tsunehiro Ando; Soichiro Ikushima; Masaru Oritsu; Tamiko Takemura
Journal:  Pathol Res Pract       Date:  2007-06-25       Impact factor: 3.250

9.  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Williamson Z Bradford; Socorro Castro-Bernardini; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Eduard Gorina; Peter M Hopkins; David Kardatzke; Lisa Lancaster; David J Lederer; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Robert Sussman; Jeffrey J Swigris; Paul W Noble
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

10.  Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of american pathologists and pulmonary pathology society.

Authors:  Victor L Roggli; Allen R Gibbs; Richard Attanoos; Andrew Churg; Helmut Popper; Philip Cagle; Bryan Corrin; Teri J Franks; Francoise Galateau-Salle; Jeff Galvin; Philip S Hasleton; Douglas W Henderson; Koichi Honma
Journal:  Arch Pathol Lab Med       Date:  2010-03       Impact factor: 5.534

View more
  9 in total

Review 1.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

2.  A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

3.  Prognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysis.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui; Shinyu Izumi; Takashi Sozu
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

Review 4.  The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis.

Authors:  Jessica Lawrence; Richard Nho
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

5.  Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2018-03-08       Impact factor: 2.692

Review 6.  The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.

Authors:  Paul D Blanc; Isabella Annesi-Maesano; John R Balmes; Kristin J Cummings; David Fishwick; David Miedinger; Nicola Murgia; Rajen N Naidoo; Carl J Reynolds; Torben Sigsgaard; Kjell Torén; Denis Vinnikov; Carrie A Redlich
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

Review 7.  Imaging diagnosis of classical and new pneumoconiosis: predominant reticular HRCT pattern.

Authors:  Akira Masanori
Journal:  Insights Imaging       Date:  2021-03-10

8.  Temporal Patterns of Exposure to Asbestos and Risk of Asbestosis: An Analysis of a Cohort of Asbestos Textile Workers.

Authors:  Andrea Farioli; Francesco S Violante; Carlo La Vecchia; Eva Negri; Claudio Pelucchi; Giovanna Spatari; Paolo Boffetta; Enrico Pira
Journal:  J Occup Environ Med       Date:  2018-06       Impact factor: 2.162

9.  Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features.

Authors:  Hiroyuki Kamiya; Ogee Mer Panlaqui
Journal:  BMJ Open       Date:  2019-12-11       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.